Souders Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$921K Sell
13,347
-4,309
-24% -$297K 0.12% 92
2025
Q1
$1.23M Sell
17,656
-11,404
-39% -$792K 0.17% 83
2024
Q4
$2.5M Sell
29,060
-10,699
-27% -$920K 0.35% 65
2024
Q3
$4.73M Buy
39,759
+63
+0.2% +$7.5K 0.66% 41
2024
Q2
$5.67M Buy
39,696
+230
+0.6% +$32.8K 0.85% 36
2024
Q1
$5.07M Sell
39,466
-2,473
-6% -$318K 0.8% 36
2023
Q4
$4.34M Sell
41,939
-584
-1% -$60.4K 0.74% 40
2023
Q3
$3.87M Sell
42,523
-7,031
-14% -$639K 0.74% 41
2023
Q2
$4.01M Sell
49,554
-4,568
-8% -$370K 0.77% 39
2023
Q1
$4.31M Sell
54,122
-334
-0.6% -$26.6K 0.91% 31
2022
Q4
$3.69M Buy
54,456
+208
+0.4% +$14.1K 0.84% 33
2022
Q3
$2.7M Sell
54,248
-10,644
-16% -$530K 0.73% 42
2022
Q2
$3.62M Buy
64,892
+452
+0.7% +$25.2K 1.04% 25
2022
Q1
$3.58M Buy
64,440
+272
+0.4% +$15.1K 1.03% 27
2021
Q4
$3.59M Sell
64,168
-1,548
-2% -$86.7K 1.03% 27
2021
Q3
$3.16M Buy
65,716
+1,020
+2% +$49K 1.02% 30
2021
Q2
$2.71M Buy
64,696
+1,212
+2% +$50.8K 0.91% 37
2021
Q1
$2.14M Buy
63,484
+2,240
+4% +$75.5K 0.84% 42
2020
Q4
$2.14M Buy
61,244
+1,204
+2% +$42.1K 0.93% 35
2020
Q3
$2.03M Buy
60,040
+2,372
+4% +$80.1K 0.96% 37
2020
Q2
$1.89M Buy
57,668
+27,798
+93% +$910K 1.08% 31
2020
Q1
$899K Buy
+29,870
New +$899K 0.79% 33